Trendlines Group Trendletter – August 2021


The Trendlines Group Trendletter | August 2021

“Trendlines announces $4.1 million profit and 10% increase in portfolio value for H1 2021… $7.5 million round for AgroScout… Vensica signs strategic partnership”



We released our H1 2021 financial results. See the announcement, press release, and earnings call recording:

H1 2021 Results Press Release
H1 2021 Unaudited Financial Results
H1 2021 Earnings Call Recording

Trendlines CFO, Haim Brosh, was quoted in an article in CTECH.



AgroScout raises $7.5 million to expand its AI-based agronomy analytics service… Read more.

Elastimed is conducting a clinical study at Sheba Medical Center and is seeking the first users of their device… Read more.


Vensica Therapeutics inks strategic partnership with Merz… Read more.

EcoPhage was selected as one of the nine top startups of the 2021 MassChallenge Israel cohort… Read more.


Vessi Medical launches FIH trial utilizing cryotherapy to remove bladder cancer tumors… Read more.



  • CEO Steve Rhodes joined the Advisory Panel of The Global Food Security & Sustainability Virtual Summit… Read more.
  • Anton Wibowo, CEO, Trendlines Agrifood Innovation Centre will be participating as a judge at SLINGSHOT 2021… Read more
  • AgriVest 2021 is coming up and registration is open.


  • Decoding NMPA – View a recording of our webinar focused on China’s NMPA regulatory process for medical device companies, by Peng Yifei, GM of Tigermed-Jyton.


  • Deal Fridays – View a recording from our virtual event showcasing six upcoming agritech start-ups, organized by Enterprise Singapore.